NCT04476472View on ClinicalTrials.gov

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

January 17, 2022

Study Completion Date

October 12, 2022

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Omnipod Horizon™ Automated Glucose Control System

The Omnipod Horizon™ Automated Glucose Control System will provide automated insulin delivery.

Trial Locations (10)

13244

SUNY Syracuse, Syracuse

22904

University of Virginia, Charlottesville

30318

Atlanta Diabetes, Atlanta

44106

University Hospitals Cleveland, Cleveland

55416

International Diabetes Center, Saint Louis Park

77030

Baylor College of Medicine, Houston

80045

University of Colorado Denver, Denver

94305

Stanford University, Palo Alto

06511

Yale University School of Medicine, New Haven

02215

Joslin Diabetes Center, Boston

Sponsors
All Listed Sponsors
lead

Insulet Corporation

INDUSTRY

NCT04476472 - Omnipod Horizon™ Automated Glucose Control System Preschool Cohort | Biotech Hunter | Biotech Hunter